According to Prometheus Biosciences's latest financial reports the company's current revenue (TTM ) is HK$31.05 Million. In 2022 the company made a revenue of HK$53.2 Million an increase over the revenue in the year 2021 that were of HK$24.39 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.